Avid Bioservices Statistics
Total Valuation
CDMO has a market cap or net worth of $783.14 million. The enterprise value is $952.19 million.
Important Dates
The next estimated earnings date is Thursday, December 5, 2024, after market close.
| Earnings Date | Dec 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CDMO has 63.96 million shares outstanding. The number of shares has increased by 1.44% in one year.
| Current Share Class | 63.96M |
| Shares Outstanding | 63.96M |
| Shares Change (YoY) | +1.44% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 1.13% |
| Owned by Institutions (%) | 89.21% |
| Float | 54.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.44 |
| Forward PS | 4.46 |
| PB Ratio | 13.29 |
| P/TBV Ratio | 13.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 104.78 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 3.54.
| Current Ratio | 1.46 |
| Quick Ratio | 1.01 |
| Debt / Equity | 3.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.18 |
Financial Efficiency
Return on equity (ROE) is -115.84% and return on invested capital (ROIC) is -3.67%.
| Return on Equity (ROE) | -115.84% |
| Return on Assets (ROA) | -3.05% |
| Return on Capital (ROIC) | -3.67% |
| Revenue Per Employee | $383,714 |
| Profits Per Employee | -$388,585 |
| Employee Count | 371 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 3.81 |
Taxes
In the past 12 months, CDMO has paid $114.43 million in taxes.
| Income Tax | 114.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +120.18% in the last 52 weeks. The beta is 1.40, so CDMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +120.18% |
| 50-Day Moving Average | 10.98 |
| 200-Day Moving Average | 8.92 |
| Relative Strength Index (RSI) | 69.44 |
| Average Volume (20 Days) | 3,726,387 |
Short Selling Information
The latest short interest is 13.51 million, so 21.12% of the outstanding shares have been sold short.
| Short Interest | 13.51M |
| Short Previous Month | 13.19M |
| Short % of Shares Out | 21.12% |
| Short % of Float | 24.94% |
| Short Ratio (days to cover) | 24.11 |
Income Statement
In the last 12 months, CDMO had revenue of $142.36 million and -$144.17 million in losses. Loss per share was -$2.28.
| Revenue | 142.36M |
| Gross Profit | 8.93M |
| Operating Income | -18.97M |
| Pretax Income | -26.93M |
| Net Income | -144.17M |
| EBITDA | -7.69M |
| EBIT | -18.97M |
| Loss Per Share | -$2.28 |
Full Income StatementBalance Sheet
The company has $36.78 million in cash and $207.43 million in debt, giving a net cash position of -$170.65 million or -$2.67 per share.
| Cash & Cash Equivalents | 36.78M |
| Total Debt | 207.43M |
| Net Cash | -170.65M |
| Net Cash Per Share | -$2.67 |
| Equity (Book Value) | 58.64M |
| Book Value Per Share | 0.92 |
| Working Capital | 32.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.51 million and capital expenditures -$18.96 million, giving a free cash flow of -$11.45 million.
| Operating Cash Flow | 7.51M |
| Capital Expenditures | -18.96M |
| Free Cash Flow | -11.45M |
| FCF Per Share | -$0.18 |
Full Cash Flow StatementMargins
Gross margin is 6.27%, with operating and profit margins of -13.33% and -101.27%.
| Gross Margin | 6.27% |
| Operating Margin | -13.33% |
| Pretax Margin | -20.88% |
| Profit Margin | -101.27% |
| EBITDA Margin | -5.40% |
| EBIT Margin | -13.33% |
| FCF Margin | -14.90% |
Dividends & Yields
CDMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.44% |
| Shareholder Yield | -1.44% |
| Earnings Yield | -18.33% |
| FCF Yield | -1.46% |
Dividend DetailsAnalyst Forecast
The average price target for CDMO is $13.63, which is 11.31% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.63 |
| Price Target Difference | 11.31% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 38.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 10, 2017. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Jul 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
CDMO has an Altman Z-Score of -0.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.97 |
| Piotroski F-Score | 4 |